References
Abba, M., & Usman, S. (2016). Corporate attributes and share value of listed pharmaceutical firms in Nigeria. Journal of Arts, Science & Commerce, 7(1), 1. Ademola, O. J., & Moses, O. I. (2017). Accounting conservatism and its benefits to shareholders in developing capital market: evidence from Nigeria. Journal of Accounting and Finance, 17(1), 89-96. Adeyemi, E., & Yahaya, O. A. (2024). The impact of board financial expertise on earnings quality in Nigerian listed companies. NDA Original Research Paper, 9(4), 1-30. Agbogun, S. A., Adejuwon, B. S., & Ojeboola, O. O. (2024). Audi characteristics and financial reporting quality of listed pharmaceutical firms in Nigeria. Lead City International Journal Of Library, Information & Communication Sciences, 1(2), 1-26. Akan, D. C., & Temile, S. O. (2024). Empirical Discourse on Accounting Conservatism and Financial Performance of Multinational Companies in Nigeria. Accounting and Management Research, 3, 13-13. Amah, K. O., & Ekwe, M. C. (2021). Effect of corporate governance structure and financial reporting quality of quoted pharmaceutical companies in Nigeria. Management dynamics in the knowledge economy, 9(2), 225-240. Arogundade, A. M., & Ajibade, A. T. (2023). Corporate governance and accounting conservatism in Nigeria: An empirical investigation. South Asian Research Journal of Business and Management, 5(3), 73-87. Asiriuwa, O., Akperi, R. T., Uwuigbe, O. R., Uwuigbe, U., Nassar, L., Ilogho, S., & Eriabe, S. (2019, September). Ownerships structures and accounting conservatism among Nigeria listed firms. In IOP Conference Series: Earth and Environmental Science (Vol. 331, No. 1, p. 012056). IOP Publishing. Azodo, A., Okoro, E., & Okorie, N. (2024). Effect of Corporate Assets on Profitability of Pharmaceutical Firms in Nigeria. Research Journal of Financial Sustainability Reporting, 7(1). Christian, O. C., Emeka-Nwokeji, N. A., & Fredrick, O. (2022). Accounting conservatism and ownership structure in non-financial listed firms in Nigeria. International Journal of Health Sciences, (II), 1533-1546. Etim, U. D., Okon, E. N., & Lateef, I. B. (2025). Financial leverage and earnings quality of listed consumer goods entities in Nigeria. British International Journal of Applied Economics, Finance and Accounting, 9(1), 1-33. Galadima, J., Adebisi, J. F., Enekwe, C. I., & Ekele, J. S. (2024). Effects of Audit Attributes on Market Value of Listed Pharmaceutical Firms in Nigeria. International Journal of Public Administration and Management Research, 10(5), 43-55. Kelvin, A. O. (2020). Firm Characteristics and Earning Quality of Quoted Manufacturing Firms in Nigeria. International Journal of Academic Reserach in Economics and Management Sciences, 9(3). Obi, T. N., & Okoye, P. V. (2023). Audit quality and earnings management of pharmaceutical companies listed in Nigeria. Journal of Global Accounting, 9(3), 322-341. Ogiriki, D. T., Buseri, T., & Owota, P. G. (2025). Audit quality and financial reporting quality of selected listed companies in Nigeria. ISIR Journal of Business and Management Studies, 2(3), 21-27. Ogiriki, T. P., & Ghandi, E. G. (2023). Audit Quality & Earnings Management of Listed Manufacturing Firms in Nigeria. International Journal of Innovative Finance and Economics Research 11(3),1-14. Ogiriki, T., & Atagboro, E. (2022). Treatment of acquired goodwill and earnings management: The Nigerian banking sector consolidation experience. Global Scientific and Academic Research Journal of Economics, Business and Management, 1(1), 28-37. Ogiriki, T., Levi, O. & Prisca, S. (2023). Audit quality and financial performamnce of listed pharmaceutical firms in Nigeria. International Journal of Financial Management and Economics, 6(1): 227-233. Okechukwu, I. J. (2022). Earnings Quality of Healthcare Companies in Nigeria Before and After IFRS Adoption. AKSU Journal of Management Sciences (AKSUJOMAS). https://doi. org/10.61090/aksujomas. Zadeh, F. N., Askarany, D., & Asl, S. A. (2022). Accounting conservatism and earnings quality. Journal of Risk and Financial Management, 15(9), 413.